Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual
- PMID: 16449185
- DOI: 10.3322/canjclin.56.1.37
Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual
Abstract
The sixth edition of the AJCC Cancer Staging Manual contains some of the most extensive and significant revisions that have ever been made in the breast cancer staging system. The principal changes are related to the size, number, location, and method of detection of regional metastases to the lymph nodes. Some changes are related to the growing use of new technology (eg, sentinel lymph node biopsy, immunohistochemical staining, reverse transcriptase-polymerase chain reaction), whereas others are amendments of prior staging criteria, reflecting recent clinical evidence or widespread clinical consensus. Available data did not support the addition of new prognostic indicators such as histologic tumor grade to the tumor-node-metastasis system at this time. Future developments in determining breast cancer prognosis will most likely incorporate new approaches to identifying the genetic fingerprint of individual tumors.
Similar articles
-
Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.Breast J. 2006 Jul-Aug;12(4):294-301. doi: 10.1111/j.1075-122X.2006.00267.x. Breast J. 2006. PMID: 16848838
-
[Comments on the new American Joint Committee on Cancer TNM staging for breast cancer. What's new for the pathologist?].Ann Pathol. 2003 Dec;23(6):492-5. Ann Pathol. 2003. PMID: 15094587 French.
-
Sentinel lymph node biopsy as an alternative to routine axillary lymph node dissection in breast cancer patients.J Surg Oncol. 2001 Feb;76(2):144-56. doi: 10.1002/1096-9098(200102)76:2<144::aid-jso1028>3.0.co;2-h. J Surg Oncol. 2001. PMID: 11223844 Review.
-
Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.CA Cancer J Clin. 2017 Jul 8;67(4):290-303. doi: 10.3322/caac.21393. Epub 2017 Mar 14. CA Cancer J Clin. 2017. PMID: 28294295
-
Revision of breast cancer staging: the 6th edition of the TNM Classification.Semin Surg Oncol. 2003;21(1):53-9. doi: 10.1002/ssu.10021. Semin Surg Oncol. 2003. PMID: 12923916 Review.
Cited by
-
Enhanced drug delivery with nanocarriers: a comprehensive review of recent advances in breast cancer detection and treatment.Discov Nano. 2024 Sep 7;19(1):143. doi: 10.1186/s11671-024-04086-6. Discov Nano. 2024. PMID: 39243326 Free PMC article. Review.
-
Correlation of immunoglobulin G expression and histological subtype and stage in breast cancer.PLoS One. 2013;8(3):e58706. doi: 10.1371/journal.pone.0058706. Epub 2013 Mar 12. PLoS One. 2013. PMID: 23554916 Free PMC article.
-
Comparisons of Oncologic Outcomes between Triple-Negative Breast Cancer (TNBC) and Non-TNBC among Patients Treated with Breast-Conserving Therapy.Yonsei Med J. 2016 Sep;57(5):1192-8. doi: 10.3349/ymj.2016.57.5.1192. Yonsei Med J. 2016. PMID: 27401651 Free PMC article.
-
The Glycolytic Phenotype is Correlated with Aggressiveness and Poor Prognosis in Invasive Ductal Carcinomas.J Breast Cancer. 2012 Jun;15(2):172-80. doi: 10.4048/jbc.2012.15.2.172. Epub 2012 Jun 28. J Breast Cancer. 2012. PMID: 22807934 Free PMC article.
-
Downregulation of transgelin 2 promotes breast cancer metastasis by activating the reactive oxygen species/nuclear factor‑κB signaling pathway.Mol Med Rep. 2019 Nov;20(5):4045-4258. doi: 10.3892/mmr.2019.10643. Epub 2019 Sep 3. Mol Med Rep. 2019. PMID: 31485630 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical